|
LINKS
| |
ISTIOCITOSI
A CELLULE DI LANGERHANS
Le
cellule di Langerhans (LC) fanno parte, con le cellule interdigitate delle zone
paracorticali del linfonodo, del sistema cellulare con funzione di
"presentazione dell'antigene". Il profilo immunofenotipico delle LC,
utile per la loro individuazione su sezioni di tessuto, comprende la proteina
S100, l'antigene CD1a e la Langerin, una proteina
implicata nella genesi dei granuli di Birbeck.
PROFILO
IMMUNOFENOTIPICO DELLE CELLULE DI LENGERHANS E DELLE CELLULE CHE PROLIFERANO
NELLA ISTIOCITOSI A CELLULE DI LANGERHANS
| |
S100 |
CD1a |
LANGERIN |
|
| CELLULE DI LANGERHANS DELL'EPIDERMIDE |
+++ |
+++ |
++ |
|
| CELLULE INTERDIGITATE DEL LINFONODO |
+++ |
-/+ |
-/+ |
|
| ISTIOCITOSI A CL |
+++ |
+++ |
++ |
|
| TUMORE A CELLULE INTERGITATE |
+++ |
- |
- |
|
In questo caso di
istiocitosi a cellule di Langerhans linfonodale si evidenziano aggregati
di
cellule monocitoidi caratterizzate da intensa espressione di CD1a ed S100.

Linfonodo
con Istiocitosi a cellule di Langerhans E.E.
CD1a
CD1a
CD1a
S100
References
-
J Clin Pathol 1982 Mar;35(3):327-37
- Combined immunological and histochemical analysis of
skin and lymph node lesions in histiocytosis X.
Thomas JA, Janossy G, Chilosi M, Pritchard J, Pincott JR
The immunological phenotype of the cells involved in skin and lymph node
lesions from two cases of histiocytosis X (H-X) were analysed by
immunofluorescence techniques using combinations of heterologous and
monoclonal antisera to Ia-like antigen and human cortical thymocyte (HTA-1)
determinant. These cells were also characterised by a new technique using
simultaneous immunofluorescence and enzyme histochemistry for acid
phosphatase (ACPase). The major cell type in the lesions was found to
express the same Ia+, HTA-1+ phenotype as normal epidermal Langerhans' cells
(LC) and was unreactive for ACPase. Additional cell types included Ia-,
HTA-1- multinucleate giant cells and residual lymphoid populations. These
findings endorse previous concepts that H-X is a proliferation of abnormal
LC and emphasise the heterogeneous nature of the cells involved in the
disease.
J Invest Dermatol 1988 Apr;90(4):441-7
- The phenotypic spectrum of histiocytosis X cells.
Groh V, Gadner H, Radaszkiewicz T, Rappersberger K, Konrad K, Wolff K,
Stingl G
Department of Dermatology I, University of Vienna Medical School, Austria.
Proliferating cells in histiocytosis X (histiocytosis X cells) share many
structural and immunophenotypic features with Langerhans cells, leading to
the assumption that histiocytosis X represents a proliferative disorder of
Langerhans cells. Because, depending on their state of activation and/or
differentiation, Langerhans cells exhibit a varying immunophenotype, we
investigated whether histiocytosis X cells display a similar phenotypic
heterogeneity and, if so, whether the heterogenous biological behavior of
histiocytosis X is reflected by differences in the immunophenotype of the
proliferating cells. In 21 patients suffering from different clinical
manifestations of histiocytosis X, proliferating cells uniformly expressed
class I and II alloantigens, T200, CD1, CD4, and S100 protein. In 12 of 21
cases, histiocytosis X cells additionally exhibited immunocytochemically
detectable amounts of C3b and C3bi receptors and certain monocyte/macrophage
antigens (CDw14, Ki-M1, Ki-M6). This immunophenotypic heterogeneity of
histiocytosis X cells could not be correlated with clinical course,
prognosis, and final outcome of the disease in a given patient. The capacity
of histiocytosis X cells to immunophenotypically mimic various states of
Langerhans cell activation and/or differentiation, however, underscores the
concept of histiocytosis X as a proliferative disorder of Langerhans cell
origin.
Mol Biol Cell 2002 Jan;13(1):317-35
- Birbeck granules are subdomains of endosomal recycling
compartment in human epidermal Langerhans cells, which form where Langerin
accumulates.
Mc Dermott R, Ziylan U, Spehner D, Bausinger H, Lipsker D, Mommaas M,
Cazenave JP, Raposo G, Goud B, de la Salle H, Salamero J, Hanau D.
Unite Mixte de Recherche 144 Centre National de la Recherche Scientifique,
Laboratoire Mecanismes Moleculaires du Transport Intracellulaire, Institut
Curie, 75248 Paris, France.
Birbeck granules are unusual rod-shaped structures specific to epidermal
Langerhans cells, whose origin and function remain undetermined. We
investigated the intracellular location and fate of Langerin, a protein
implicated in Birbeck granule biogenesis, in human epidermal Langerhans
cells. In the steady state, Langerin is predominantly found in the endosomal
recycling compartment and in Birbeck granules. Langerin internalizes by
classical receptor-mediated endocytosis and the first Birbeck granules
accessible to endocytosed Langerin are those connected to recycling
endosomes in the pericentriolar area, where Langerin accumulates.
Drug-induced inhibition of endocytosis results in the appearance of abundant
open-ended Birbeck granule-like structures appended to the plasma membrane,
whereas inhibition of recycling induces Birbeck granules to merge with a
tubular endosomal network. In mature Langerhans cells, Langerin traffic is
abolished and the loss of internal Langerin is associated with a concomitant
depletion of Birbeck granules. Our results demonstrate an exchange of
Langerin between early endosomal compartments and the plasma membrane, with
dynamic retention in the endosomal recycling compartment. They show that
Birbeck granules are not endocytotic structures, rather they are subdomains
of the endosomal recycling compartment that form where Langerin accumulates.
Finally, our results implicate ADP-ribosylation factor proteins in Langerin
trafficking and the exchange between Birbeck granules and other endosomal
membranes.
|